1,715 results on '"Chen, Zhe-Sheng"'
Search Results
52. Therapeutic Efficacy of Roscovitine Against Cancer
53. A Critical Appraisal of Current Status of Synthetic Antioxidant Molecules in the Treatment of Breast Cancer
54. Oxidative Stress Modulation by G-quadruplex Binder-Naphthalene Diimide Derivatives and Its Therapeutic Potential
55. Recent Advances in the Development of Synthetic Pro-oxidants: Implications for ROS-Based Cancer Therapeutics : Implications for ROS-Based Cancer Therapeutics
56. Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
57. CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis
58. ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance
59. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
60. Chemical derivatization leads to the discovery of novel analogs of azotochelin, a natural siderophore, as promising anticancer agents
61. A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple‐positive breast cancer
62. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN
63. PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study
64. m6A modification: recent advances, anticancer targeted drug discovery and beyond
65. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma
66. Signaling pathways and therapeutic interventions in gastric cancer
67. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
68. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
69. Microbiota in health and diseases
70. Proteomics technologies for cancer liquid biopsies
71. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
72. Gut microbes regulate the feeding center: a new discovery of Gut Brain Axis
73. Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure
74. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
75. Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum maxim. as PDE5A inhibitors
76. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p
77. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
78. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
79. Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin
80. RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.
81. The Oncogenic Protein, Breakpoint Cluster (BCR)-Abelson Kinase (ABL) and Chronic Myelocytic Leukemia (CML): Insight Into the Drug Resistance Mechanisms and Approaches for Targeting BCR-ABL in CML
82. Paclitaxel and chemoresistance
83. Preface
84. Paclitaxel and cancer treatment: Non-mitotic mechanisms of paclitaxel action in cancer therapy
85. Contributors
86. HER2+ advanced gastric cancer: Current state and opportunities (Review)
87. Combating antimicrobial resistance: the silent war
88. Characterization of the Nucleus Pulposus Progenitor Cells via Spatial Transcriptomics
89. Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke
90. Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
91. Editorial: DNA methylation, tumor microenvironment and their effects in immunotherapy and drug resistance in thoracic tumors
92. Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR‐27b‐3p targeting the SIK1‐CREB1 axis
93. Cell death in cancer chemotherapy using taxanes
94. Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma
95. Mechanisms of thrombosis and research progress on targeted antithrombotic drugs
96. Formulation and characterization of oleic acid magnetic PEG PLGA nanoparticles for targeting glioblastoma multiforme
97. Novel nanomedicines to overcome cancer multidrug resistance
98. CUL4high Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival
99. Editorial: Biological macromolecules from marine organisms: isolation, characterization and pharmacological activities
100. Recent progress on targeting leukemia stem cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.